176 results on '"FEDELE, ROBERTA"'
Search Results
2. Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells
3. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19
4. Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients
5. Mobilization of Hematopoietic Stem Cells with Lenograstim in Healthy Donors: Efficacy and Safety Analysis According to Donor Age
6. Tolerability and Efficacy of Busulfan and Fludarabine As Allogeneic Pretransplant Conditioning Therapy in Acute Myeloid Leukemia: Comparison With Busulfan and Cyclophosphamide Regimen
7. Multi-Omics Studies Unveil Extraciliary Functions of BBS10 and Show Metabolic Aberrations Underlying Renal Disease in Bardet–Biedl Syndrome
8. Machine Learning and Personalized Modeling Based Gene Selection for Acute GvHD Gene Expression Data Analysis
9. Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry
10. Long-Term Results in Multiple Myeloma After High-Dose Melphalan and Autologous Transplantation According to Response Categories in the Era of Old Drugs
11. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
12. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19
13. Studio della mammella con protesi in tomosintesi
14. The Serum Metabolome of Moderate and Severe COVID-19 Patients Reflects Possible Liver Alterations Involving Carbon and Nitrogen Metabolism
15. Mobilization of hematopoietic progenitor stem cells in allogeneic setting with lenograstim by subcutaneous injection, in daily or twice-daily dosing: a single-center prospective study with historical control
16. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study
17. Physicochemically modified silicon as a substrate for protein microarrays
18. Dataset of a comparative proteomics experiment in a methylmalonyl-CoA mutase knockout HEK 293 cell model
19. Machine Learning and Personalized Modeling Based Gene Selection for Acute GvHD Gene Expression Data Analysis
20. Proteomics Reveals that Methylmalonyl-CoA Mutase Modulates Cell Architecture and Increases Susceptibility to Stress
21. Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism
22. Occupational asthma due to exposure to iroko wood dust
23. Chemotherapy and Cardiotoxicity in Hematologic Malignancies
24. Basal CD34+ Cell Count Predicts Peripheral Blood Hematopoietic Progenitor Cells Mobilization in Healthy Donors after Administration of G-CSF
25. Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
26. Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry
27. Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation
28. Salvage treatment for relapsed/refractory Hodgkin lymphoma: role of allografting, brentuximab vedotin and newer agents
29. The role of tandem stem cell transplantation for multiple myeloma patients
30. A Phase 2 Study of Bendamustine Plus Melphalan Conditioning for Second Autologous Stem Cell Transplantation in "De-Novo" Multiple Myeloma Patients in a Tandem Transplant Strategy
31. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy
32. Allogeneic stem cell transplantation in multiple myeloma: immunotherapy and new drugs
33. Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience
34. Biosimilar Compared with Originator Filgrastim for Autologous Stems CELL Mobilisation: A Prospective-Historical Control Study in Multiple Myeloma REAL-Life Setting
35. Bendamustine Plus Melphalan As Conditioning Regimen for Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma: Single Centre Experience
36. A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study
37. Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)
38. Optimizing Outcomes Following Allogeneic Hematopoietic Progenitor Cell Transplantation in AML: The Role of Hypomethylating Agents
39. Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma
40. Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma
41. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.
42. Autologous hematopoietic progenitor cell transplantation for multiple myeloma through an outpatient program
43. Long-term results in multiple myeloma treated with high-dose melphalan and autologous peripheral stem cell transplantation and achieving complete remission.
44. Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art
45. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?
46. Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study
47. At-Home Management of Aplastic Phase Following High-Dose Melphalan and Autologous Haematopoietic Stem Cell Transplantation for Multiple Myeloma Patients: A Pilot Study
48. Imatinib mesylate in T-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease
49. W1173 An In Vivo Study to Evaluate MLCK Expression in Patients with Inflammatory Bowel Diseases
50. A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.